Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

G.Barekat Pharm

PUBLIC STATUS
$0.04 SHARE PRICE (As of Monday Closing)
Description

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Business Products and Services
Former Stock Listing
BRKT1
Primary Office
  • Tehran
  • Iran
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore G.Barekat Pharm’s full profile, request a free trial.

G.Barekat Pharm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.02 - $0.05 $0.03 3.38M
Public Fundamental Data provided by Morningstar, Inc. disclaimer